Picture of Illumina logo

ILMN Illumina Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Annual income statement for Illumina, fiscal year end - December 29th, USD millions except per share, conversion factor applied.

2021
January 3rd
2022
January 2nd
2023
December 31st
2023
January 1st
2024
December 29th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3,2394,5264,5044,5844,372
Cost of Revenue
Gross Profit2,2033,1542,7442,9722,861
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses2,6594,6495,5738,7635,205
Operating Profit580-123-1,069-4,179-833
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes856884-1,117-4,336-1,179
Provision for Income Taxes
Net Income After Taxes656762-1,161-4,404-1,223
Minority Interest
Net Income Before Extraordinary Items
Net Income656762-1,161-4,404-1,223
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income656762-1,161-4,404-1,223
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS4.435.05-3.24-9.28-1.58